Avoiding and Managing Complications: Hyperpigmentation and Scarring
Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium interviewed Dr. Andrew Alexis, professor of clinical dermatology and vice-chair for diversity and inclusion for the Weill Cornell Medical College Department of Dermatology. Watch as Dr. Alexis outlines how to avoid hyperpigmentation and scarring when performing a cosmetic procedure. Learn simple questions you can ask t …
Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium interviewed Dr. Andrew Alexis, professor of clinical dermatology and vice-chair for diversity and inclusion for the Weill Cornell Medical College Department of Dermatology. Watch as Dr. Alexis outlines how to avoid hyperpigmentation and scarring when performing a cosmetic procedure. Learn simple questions you can ask t … Continue reading "Avoiding and Managing Complications: Hyperpigmentation and Scarring"
ABSTRACT
Dyschromia is a concern for many patients, especially persons of color. Postinflammatory hypopigmentation and depigmentation can affect all skin types; however, it is more apparent in those with darker skin. Some members of the dermatology community may not comprehensively understand the mechanisms of these reactions and the extent of the psychosocial effect they have on persons of color … 
Which of the following is least likely to be a manifestation of the skin findings shown?
A. Behcet disease
B. Psoriasis
C. Pemphigus foliaceus
D. Drug reaction
E. Sezary syndrome
To find out the correct answer and read the explanation, click here. … 
Topical minoxidil and, more recently, low-dose oral minoxidil are often used to treat hair disorders. But are these treatments safe and effective for scarring alopecia? A scoping review published in the March issue of the Journal of Drugs in Dermatology sought to determine what research says about the use of these treatments for central centrifugal cicatricial alopecia, frontal fibrosing alopecia, … 
It’s an exciting time for new therapies in atopic dermatitis with several therapies recently approved or in late-stage development. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Baltimore dermatologist Dr. Shawn Kwatra, who outlined the new treatment options. From therapies that target IL-13 and IL-31 to JAK inhibitors, dermatology cl …